Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1.
about
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamilyRole of epigenetic aberrations in the development and progression of human hepatocellular carcinomaBiallelic inactivation of the RIZ1 gene in human gastric cancerAltered expression of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukaemiaPRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencingDetection of frameshift mutations of RIZ in gastric cancers with microsatellite instabilityThe tumor suppressor PRDM5 regulates Wnt signaling at early stages of zebrafish development.RIZ1 negatively regulates ubiquitin-conjugating enzyme E2C/UbcH10 via targeting c-Myc in meningioma.Histone methyltransferases, diet nutrients and tumour suppressors.Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration.Anticancer activity of the PR domain of tumor suppressor RIZ1.Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis.Structural and functional characterization of the acidic region from the RIZ tumor suppressor.RIZ1: a potential tumor suppressor in glioma.DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer.Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes.Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinomaPreferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma.Cancer genetics of epigenetic genes.Cloning, expression, purification and crystallization of the PR domain of human retinoblastoma protein-binding zinc finger protein 1 (RIZ1)RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression.Construction of PR domain eukaryotic expression vector and its inhibitory effect on esophageal cancer cellsPRDM5 promotes the proliferation and invasion of murine melanoma cells through up-regulating JNK expression.Critical Function of PRDM2 in the Neoplastic Growth of Testicular Germ Cell Tumors.The PR-Set7 binding domain of Riz1 is required for the H4K20me1-H3K9me1 trans-tail 'histone code' and Riz1 tumor suppressor function.Context-specific regulation of cancer epigenomes by histone and transcription factor methylation.Retinoblastoma protein-interacting zinc finger 1 (RIZ1) regulates the proliferation of monocytic leukemia cells via activation of p53.Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines.Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylation.PRDM6 is enriched in vascular precursors during development and inhibits endothelial cell proliferation, survival, and differentiation.Dependence-induced increase of alcohol self-administration and compulsive drinking mediated by the histone methyltransferase PRDM2.EP4 agonist alleviates indomethacin-induced gastric lesions and promotes chronic gastric ulcer healing.
P2860
Q24291648-B3065FE1-7CCE-45B5-9789-DA7D683B1664Q27023524-D7EE785B-BC47-4B89-A910-E7194B3284A7Q28208181-360E22A9-80DC-441C-B102-D56A32D228D4Q28216917-DF41810E-A03D-48EB-9B89-3B1152442FCEQ28247014-C8D82E22-9733-4E84-9F29-E5AD65BDB129Q28277027-4875FB2C-B846-442B-805B-D10405BA54EDQ33402914-EB3348EE-FDC8-4C62-8171-19A978A4F153Q33733305-EF7CB871-4BC9-4679-8AD8-92DD70A59D95Q34145412-BA392747-9D58-4ED3-A730-54E576A993DBQ34225365-83C5BE14-5237-4599-BE87-0B498DF9E823Q34616503-CC95CC54-3D33-4B45-97A4-5FD8F1C4250FQ35078813-5EB7EC88-26D6-45BD-BD41-F11713577FB4Q35212118-90E78845-0431-4526-A104-CED8A2C15C6BQ35874592-854B7E27-6AA4-4D7E-9985-3A758E4DA36FQ35958559-08DB37E3-7BF7-4516-A8DA-9472A03776DAQ36088957-972744F4-F6A7-4E23-AC33-7F13B1F193E2Q36244079-7F9A8E0C-D6AB-4CC4-B218-7F593126B47AQ36622765-FA1CD683-4010-4038-9A35-E97C0D6634F2Q36871595-42978B84-880B-4D13-AEC6-593CFCD9F78FQ37135805-5C52AB54-A467-4B30-B6BB-5C6B2E1A5352Q37285872-3FCEC10F-070B-4273-BAC0-2AD85BE74230Q37309440-8A97153E-4899-4DC6-BC1B-AAD2AF491E3BQ37321023-58218B04-439F-459B-9B1B-1E27C44BFFF3Q37539360-D36FF1C2-D8C1-47F4-B0A1-E790375442E3Q37680327-F6674A8D-42FA-4DA9-A1AE-A290A55F0056Q38090433-FFC4BF37-286E-4698-9750-5905AF5840B6Q38342848-B45038A5-291B-435D-80A4-58AF83727F23Q39556436-A3205713-ED03-41A7-9918-CC15153B563DQ40070601-DCCA34B1-B65A-4E2D-84E3-F005001B1CE4Q40100709-2F24ED64-5830-400E-94B5-8A96497FFF38Q40602521-9EC35892-F874-4F01-9DF0-CB3F09F13967Q42620166-4EFE246C-B537-42BD-B2D4-589D7400A2A6
P2860
Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Decreased RIZ1 expression but ...... patoma tumorigenicity by RIZ1.
@en
type
label
Decreased RIZ1 expression but ...... patoma tumorigenicity by RIZ1.
@en
prefLabel
Decreased RIZ1 expression but ...... patoma tumorigenicity by RIZ1.
@en
P2093
P2860
P1476
Decreased RIZ1 expression but ...... patoma tumorigenicity by RIZ1.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0215(19991112)83:4<541::AID-IJC17>3.0.CO;2-F
P577
1999-11-01T00:00:00Z